No Data
Cassava Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/19/2024 — HC Wainwright & Co. Reiterates → Neutral 07/01/2024 — Jones Trading Downgrades Buy → Hold 0
H.C. Wainwright Maintains Cassava Sciences(SAVA.US) With Hold Rating
H.C. Wainwright analyst Vernon Bernardino maintains $Cassava Sciences(SAVA.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 26.3% and a total average return of 7.7
H.C. Wainwright Sticks to Their Hold Rating for Cassava Sciences (SAVA)
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index up 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%.The iShares Biotechnology ETF (IBB) was falling 1
Sector Update: Health Care
Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index up 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%.The iShares Biotechnology ETF (IBB) was falling 1
Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials
Cassava Sciences Inc (NASDAQ:SAVA) stock is trading lower on Wednesday on a heavy session volume of 14.35 million, as per data from Benzinga Pro.The Board of Directors appointed Richard (Rick) Barry